Published in Addiction on October 25, 2013
Letter from the Global Alcohol Producers Group. Addiction (2014) 1.70
Comparing global alcohol and tobacco control efforts: network formation and evolution in international health governance. Health Policy Plan (2016) 1.04
Alcohol harm reduction: corporate capture of a key concept. PLoS Med (2014) 0.83
Content Themes of Alcohol Advertising in U.S. Television-Latent Class Analysis. Alcohol Clin Exp Res (2015) 0.83
Observations on industry involvement in public health policy in Asia-Pacific. Addiction (2014) 0.75
Skirmishes. Addiction (2014) 0.75
Harms from other people's drinking: an international survey of their occurrence, impacts on feeling safe and legislation relating to their control. BMJ Open (2015) 0.75
Addiction editors respond to Mr. Leverton. Addiction (2014) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci (2011) 11.79
Time for a change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction (2005) 8.61
Grand challenges in global mental health. Nature (2011) 8.40
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62
Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 6.36
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: a decision that should be reversed. Addiction (2004) 5.61
Why evidence for the fetal origins of adult disease might be a statistical artifact: the "reversal paradox" for the relation between birth weight and blood pressure in later life. Am J Epidemiol (2005) 4.81
Toward more responsive and effective intervention systems for alcohol-related problems. Addiction (2002) 4.59
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction (2005) 3.95
Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction (2012) 3.91
Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction (2011) 3.80
Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav (2008) 3.52
Be aware of Drinkaware. Addiction (2013) 3.50
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med (2007) 3.45
Addiction, neuroscience and ethics. Addiction (2003) 3.44
The integrity of the science base: a test case. Addiction (2005) 3.40
Cannabis use and mental health in young people: cohort study. BMJ (2002) 3.26
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17
Electronic support groups for breast carcinoma: a clinical trial of effectiveness. Cancer (2003) 2.93
Exploring the association between cannabis use and depression. Addiction (2003) 2.92
Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction (2010) 2.87
Ethical concerns in the community about technologies to extend human life span. Am J Bioeth (2009) 2.87
Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav (2010) 2.78
Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction (2014) 2.73
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A (2006) 2.72
Heroin overdose: research and evidence-based intervention. J Urban Health (2003) 2.66
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction (2012) 2.64
A randomized controlled trial of an internet-based intervention for alcohol abusers. Addiction (2009) 2.61
Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev (2009) 2.58
Social networks as mediators of the effect of Alcoholics Anonymous. Addiction (2002) 2.52
Is cannabis use a contributory cause of psychosis? Can J Psychiatry (2006) 2.42
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res (2004) 2.34
Smoking prevalence in England is below 20% for the first time in 80 years. BMJ (2014) 2.31
Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med (2016) 2.24
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Identification of behaviour change techniques to reduce excessive alcohol consumption. Addiction (2012) 2.21
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend (2009) 2.20
Proposals to trial deep brain stimulation to treat addiction are premature. Addiction (2011) 2.17
Compulsory detention, forced detoxification and enforced labour are not ethically acceptable or effective ways to treat addiction. Addiction (2012) 2.15
Contingency management for treatment of substance abuse. Annu Rev Clin Psychol (2006) 2.13
Should smokers be offered assistance with stopping? Addiction (2010) 2.07
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend (2003) 2.05
Reducing intoxication among bar patrons: some lessons from prevention of drinking and driving. Addiction (2013) 2.02
Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users. Nicotine Tob Res (2006) 2.01
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med (2006) 1.88
What makes for an effective stop-smoking service? Thorax (2011) 1.87
Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol (2013) 1.86
A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med (2009) 1.84
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81
Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction (2012) 1.80
Failure to report attempts to quit smoking. Addict Behav (2010) 1.80
Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med (2006) 1.79
Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend (2004) 1.71
Cytisine for smoking cessation: a research agenda. Drug Alcohol Depend (2007) 1.70
Patellar resurfacing in total knee arthroplasty: does design matter? A meta-analysis of 7075 cases. J Bone Joint Surg Am (2011) 1.69
'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health (2011) 1.68
The most "successful" method for failing to quit smoking is unassisted cessation. Nicotine Tob Res (2012) 1.67
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry (2006) 1.66
Alcoholics anonymous involvement and positive alcohol-related outcomes: cause, consequence, or just a correlate? A prospective 2-year study of 2,319 alcohol-dependent men. J Consult Clin Psychol (2003) 1.65
Factors associated with the use of aids to cessation in English smokers. Addiction (2009) 1.65
Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction (2013) 1.64
Distinct neural circuits support transient and sustained processes in prospective memory and working memory. Cereb Cortex (2008) 1.63
High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer. Breast Cancer Res (2012) 1.63
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain (2015) 1.62
Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) (2010) 1.62
'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction (2013) 1.60
Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction (2007) 1.60
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med (2003) 1.60
Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction (2008) 1.59
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Identifying evidence-based competences required to deliver behavioural support for smoking cessation. Ann Behav Med (2011) 1.58
The clinical significance of "small" effects of smoking cessation treatments. Addiction (2007) 1.57
Unplanned quit attempts--results from a U.S. sample of smokers and ex-smokers. Nicotine Tob Res (2009) 1.57
Changes in smoking prevalence in 16-17-year-old versus older adults following a rise in legal age of sale: findings from an English population study. Addiction (2010) 1.55
Early dating predicts smoking during adolescence: A prospective study. Addiction (2006) 1.55
Formative evaluation and three-month follow-up of an online personalized assessment feedback intervention for problem drinkers. J Med Internet Res (2006) 1.54
A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat (2010) 1.54
Depression increases diabetes symptoms by complicating patients' self-care adherence. Diabetes Educ (2004) 1.54
Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. Int J Drug Policy (2009) 1.53
Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res (2009) 1.53
Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. Am J Public Health (2011) 1.51
Underrepresentation of African Americans in online cancer support groups. J Natl Med Assoc (2008) 1.50
Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend (2003) 1.49
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (2014) 1.49